These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27431632)

  • 1. [Hypocalcemia Induced by Denosumab in Patients with Renal Insufficiency].
    Ishida K; Shimizu R; Endo I; Miyamoto S; Kawakami K
    Gan To Kagaku Ryoho; 2016 Jul; 43(7):875-8. PubMed ID: 27431632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency.
    Miyaoka D; Imanishi Y; Ohara M; Hayashi N; Nagata Y; Yamada S; Mori K; Emoto M; Inaba M
    Osteoporos Int; 2019 Jan; 30(1):241-249. PubMed ID: 30187112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of denosumab in metastatic solid tumor patients with renal insufficiency.
    Watkins KR; Rogers JE; Atkinson B
    Support Care Cancer; 2015 Jun; 23(6):1657-62. PubMed ID: 25421444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denosumab-induced hypocalcemia in patients with solid tumors and renal dysfunction: a multicenter, retrospective, observational study.
    Nakamura K; Kaya M; Yanagisawa Y; Yamamoto K; Takayashiki N; Ukita H; Nagura M; Sugiue K; Kitajima M; Hirano K; Ishida H; Onoda C; Kobayashi Y; Nakatani E; Odagiri K; Suzuki T
    BMC Cancer; 2024 Feb; 24(1):218. PubMed ID: 38360579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of denosumab-induced hypocalcaemia in a patient with non-metastatic prostate cancer and renal impairment.
    Blackley S; Anderson K; Berg J
    J R Coll Physicians Edinb; 2015; 45(2):133-5. PubMed ID: 26181529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of denosumab-induced hypocalcemia: a retrospective observational study of patients routinely monitored with ionized calcium post-injection.
    Spångeus A; Rydetun J; Woisetschläger M
    Osteoporos Int; 2024 Jan; 35(1):173-180. PubMed ID: 37750930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Analysis of Denosumab-Induced Hypocalcemia in Bone Metastasis Treatment: Renal Dysfunction Is Not a Risk Factor for Its Incidence in a Strict Denosumab Administration Management System with Calcium/Vitamin D Supplementation.
    Saito Y; Takekuma Y; Komatsu Y; Sugawara M
    Biol Pharm Bull; 2021; 44(12):1819-1823. PubMed ID: 34853264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High serum ALP level is associated with increased risk of denosumab-related hypocalcemia in patients with bone metastases from solid tumors.
    Kinoshita Y; Arai M; Ito N; Takashi Y; Makita N; Nangaku M; Shinoda Y; Fukumoto S
    Endocr J; 2016 May; 63(5):479-84. PubMed ID: 26860123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of denosumab in osteoporotic hemodialysed patients.
    Festuccia F; Jafari MT; Moioli A; Fofi C; Barberi S; Amendola S; Sciacchitano S; Punzo G; Menè P
    J Nephrol; 2017 Apr; 30(2):271-279. PubMed ID: 27394428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmaceutical Intervention According to Strict Management System Can Normalize Decreased Serum Calcium Level by Denosumab and Prevent Its Aggravation].
    Saito Y; Uchiyama K; Sakamoto T; Yamazaki K; Kubota K; Takekuma Y; Komatsu Y; Sugawara M
    Yakugaku Zasshi; 2021; 141(8):1023-1030. PubMed ID: 34334547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of hypocalcemia in patients receiving denosumab for prevention of skeletal-related events in bone metastasis.
    Yerram P; Kansagra S; Abdelghany O
    J Oncol Pharm Pract; 2017 Apr; 23(3):179-184. PubMed ID: 26830549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denosumab-induced severe hypocalcemia in a patient with Paget's disease of bone and impaired renal function.
    Kostine M; Mehsen-Cetre N; Bannwarth B
    Therapie; 2017 Jun; 72(3):383-385. PubMed ID: 27745697
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypocalcemia post denosumab in patients with chronic kidney disease stage 4-5.
    Dave V; Chiang CY; Booth J; Mount PF
    Am J Nephrol; 2015; 41(2):129-37. PubMed ID: 25790847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the risk factors associated with hypocalcemia induced by denosumab.
    Okada N; Kawazoe K; Teraoka K; Kujime T; Abe M; Shinohara Y; Minakuchi K
    Biol Pharm Bull; 2013; 36(10):1622-6. PubMed ID: 23934346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hypocalcaemia following denosumab in heart and lung transplant patients with osteoporosis.
    Shrosbree JE; Elder GJ; Eisman JA; Center JR
    Intern Med J; 2018 Jun; 48(6):681-687. PubMed ID: 29363863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denosumab-induced hypocalcaemia in high bone turnover states of malignancy and secondary hyperparathyroidism from renal failure.
    Farinola N; Kanjanapan Y
    Intern Med J; 2013 Nov; 43(11):1243-6. PubMed ID: 24237647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid progression of vascular and soft tissue calcification while being managed for severe and persistent hypocalcemia induced by denosumab treatment in a patient with multiple myeloma and chronic kidney disease.
    Ueki K; Yamada S; Tsuchimoto A; Tokumoto M; Kumano T; Kitazono T; Tsuruya K
    Intern Med; 2015; 54(20):2637-42. PubMed ID: 26466702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab-Associated Severe Hypocalcemia in a Patient With Chronic Kidney Disease.
    Salim SA; Nair LR; Thomas L; Garla V; Palabindala V; Agarwal M; Fülöp T
    Am J Med Sci; 2018 May; 355(5):506-509. PubMed ID: 29753381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hypocalcemia following denosumab treatment in a patient with secondary osteoporosis associated with primary sclerosing cholangitis.
    Yasuda Y; Iwama S; Arima H
    Endocr J; 2019 Mar; 66(3):271-275. PubMed ID: 30713246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life-threatening hypocalcemia associated with denosumab in a patient with moderate renal insufficiency.
    Ungprasert P; Cheungpasitporn W; Srivali N; Kittanamongkolchai W; Bischof EF
    Am J Emerg Med; 2013 Apr; 31(4):756.e1-2. PubMed ID: 23399342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.